Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats
Dosing is individualized based on body weight, age, and clinical response, with typical starting doses of 1.6 mcg/kg/day in younger adults
If someone drastically limits caloric intake or routinely goes 24 hours without eating, the body shifts energy toward essential biological processes and away from nonessential ones, Rossi says
(updated for Phase 3) Garvey WT, et al
The combination of a levonorgestrel-releasing intrauterine device (LNG-IUD), metformin, and liraglutide has been shown to safely and effectively improve endometrial hyperplasia in obese patients, as well as promote the regression of early-stage endometrial cancer [41]
Type 2 Diabetes Segment Accounts for the Largest Share of the GLP-1 Market In terms of the target indication, the market is segmented into Alzheimer's Disease, non-alcoholic steatohepatitis, obesity, sleep apnea, and type 2 diabetes
